Knight Therapeutics Inc.
GUD.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.36M | 111.31M | 120.12M | 127.55M | 115.05M |
| Total Receivables | 78.97M | 101.85M | 78.91M | 76.24M | 69.34M |
| Inventory | 108.99M | 97.51M | 71.38M | 85.09M | 75.73M |
| Prepaid Expenses | 5.39M | 5.19M | 5.38M | 5.39M | 3.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 278.71M | 315.86M | 275.79M | 294.29M | 263.48M |
|
|
|||||
| Total Current Assets | 278.71M | 315.86M | 275.79M | 294.29M | 263.48M |
| Net Property, Plant & Equipment | 15.00M | 14.59M | 13.92M | 16.02M | 15.70M |
| Long-term Investments | 66.59M | 62.63M | 60.10M | 62.76M | 61.82M |
| Goodwill | 66.59M | 62.63M | 60.10M | 62.76M | 61.82M |
| Total Other Intangibles | 281.61M | 189.97M | 197.11M | 207.03M | 215.94M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.96M | 53.91M | 51.05M | 54.02M | 52.74M |
| Total Assets | 761.03M | 697.84M | 669.84M | 712.31M | 690.73M |
|
|
|||||
| Total Accounts Payable | 76.94M | 81.92M | 54.45M | 64.12M | 56.85M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 1.47M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.29M | 16.84M | 12.52M | 16.07M | 14.29M |
| Total Finance Division Other Current Liabilities | 19.65M | 7.41M | 8.88M | 7.27M | 6.18M |
| Total Other Current Liabilities | 19.65M | 7.41M | 8.88M | 7.27M | 6.18M |
| Total Current Liabilities | 112.88M | 106.18M | 77.32M | 87.46M | 77.32M |
|
|
|||||
| Total Current Liabilities | 112.88M | 106.18M | 77.32M | 87.46M | 77.32M |
| Long-Term Debt | 57.81M | 18.32M | 18.00M | 24.40M | 24.82M |
| Short-term Debt | -- | -- | 1.47M | -- | -- |
| Capital Leases | 2.70M | 2.35M | 2.39M | 2.63M | 3.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.16M | 17.59M | 19.54M | 24.96M | 27.90M |
| Total Liabilities | 201.55M | 144.44M | 117.24M | 139.45M | 133.39M |
|
|
|||||
| Common Stock & APIC | 410.99M | 388.13M | 389.18M | 418.62M | 413.99M |
| Retained Earnings | 105.74M | 109.09M | 107.58M | 106.73M | 105.40M |
| Treasury Stock & Other | 42.76M | 56.18M | 55.83M | 47.52M | 37.95M |
| Total Common Equity | 559.48M | 553.41M | 552.60M | 572.86M | 557.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 559.48M | 553.41M | 552.60M | 572.86M | 557.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 559.48M | 553.41M | 552.60M | 572.86M | 557.34M |
|
|
|||||